IAM Advisory LLC Takes Position in UnitedHealth Group Incorporated (NYSE:UNH)

IAM Advisory LLC acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 2,729 shares of the healthcare conglomerate’s stock, valued at approximately $1,105,000.

Other hedge funds have also recently added to or reduced their stakes in the company. OLD Mission Capital LLC acquired a new position in shares of UnitedHealth Group during the third quarter valued at about $439,000. Camden National Bank increased its holdings in shares of UnitedHealth Group by 5.5% during the fourth quarter. Camden National Bank now owns 1,902 shares of the healthcare conglomerate’s stock valued at $667,000 after acquiring an additional 100 shares in the last quarter. Hoylecohen LLC increased its holdings in shares of UnitedHealth Group by 9.0% during the first quarter. Hoylecohen LLC now owns 1,149 shares of the healthcare conglomerate’s stock valued at $428,000 after acquiring an additional 95 shares in the last quarter. Cubist Systematic Strategies LLC boosted its position in UnitedHealth Group by 216.8% in the first quarter. Cubist Systematic Strategies LLC now owns 8,130 shares of the healthcare conglomerate’s stock valued at $3,025,000 after buying an additional 5,564 shares during the last quarter. Finally, Axiom Investment Management LLC purchased a new stake in UnitedHealth Group in the first quarter valued at approximately $242,000. Hedge funds and other institutional investors own 86.20% of the company’s stock.

A number of equities research analysts recently commented on the company. Morgan Stanley upped their target price on UnitedHealth Group from $488.00 to $499.00 and gave the company an “overweight” rating in a research report on Friday, October 15th. Deutsche Bank Aktiengesellschaft upped their price objective on UnitedHealth Group from $421.00 to $477.00 and gave the stock a “buy” rating in a research report on Tuesday, November 16th. Wells Fargo & Company increased their price objective on UnitedHealth Group from $478.00 to $520.00 and gave the company an “overweight” rating in a research note on Monday, October 25th. Cowen began coverage on UnitedHealth Group in a research note on Thursday, September 9th. They issued an “outperform” rating and a $478.00 price objective for the company. Finally, Credit Suisse Group raised their target price on UnitedHealth Group from $462.00 to $495.00 and gave the stock an “outperform” rating in a research note on Friday, October 15th. One investment analyst has rated the stock with a hold rating, twenty-one have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of $477.35.

In other news, Director Stephen J. Hemsley sold 75,000 shares of the firm’s stock in a transaction dated Monday, October 25th. The stock was sold at an average price of $448.72, for a total transaction of $33,654,000.00. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Richard T. Burke sold 2,500 shares of UnitedHealth Group stock in a transaction that occurred on Friday, September 17th. The stock was sold at an average price of $419.00, for a total value of $1,047,500.00. The disclosure for this sale can be found here. Insiders sold a total of 82,500 shares of company stock valued at $36,855,125 in the last quarter. Company insiders own 0.55% of the company’s stock.

Shares of UnitedHealth Group stock opened at $450.16 on Thursday. The business has a 50-day moving average of $430.47 and a 200 day moving average of $418.01. UnitedHealth Group Incorporated has a 12 month low of $320.35 and a 12 month high of $466.00. The stock has a market capitalization of $423.98 billion, a price-to-earnings ratio of 27.93, a price-to-earnings-growth ratio of 1.75 and a beta of 0.85. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.77 and a quick ratio of 0.77.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, October 14th. The healthcare conglomerate reported $4.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.41 by $0.11. The business had revenue of $72.34 billion during the quarter, compared to analysts’ expectations of $71.24 billion. UnitedHealth Group had a return on equity of 23.08% and a net margin of 5.52%. The business’s quarterly revenue was up 11.1% compared to the same quarter last year. During the same quarter last year, the business posted $3.51 EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 18.84 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 14th. Stockholders of record on Monday, December 6th will be paid a $1.45 dividend. This represents a $5.80 annualized dividend and a dividend yield of 1.29%. The ex-dividend date of this dividend is Friday, December 3rd. UnitedHealth Group’s payout ratio is presently 35.98%.

UnitedHealth Group Profile

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

See Also: Cost of Debt

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.